Da R, Wang M, Jiang H, Wang W, et al. BRAF-amplified glioblastoma patients have a worse prognosis than those with BRAF mutation and are associated with amplification of MET, RHEB and CUL1. BMC Neurol 2026 May 18. doi: 10.1186/s12883-026-04982.
PMID: 42144589